Table of Contents Table of Contents
Previous Page  453 / 670 Next Page
Information
Show Menu
Previous Page 453 / 670 Next Page
Page Background

‹ $2$& ,17(51$7,21$/

$2$& 6035

6WDQGDUG 0HWKRG 3HUIRUPDQFH 5HTXLUHPHQWV

IRU 'HWHUPLQDWLRQ RI )OXRULGH LQ ,QIDQW DQG

$GXOW 3HGLDWULF 1XWULWLRQDO )RUPXOD

,QWHQGHG 8VH 5HIHUHQFH 0HWKRG IRU 'LVSXWH 5HVROXWLRQ

1 Applicability

'HWHUPLQDWLRQ RI

ÀXRULGH

LQ DOO IRUPV RI LQIDQW DGXOW DQG

RU SHGLDWULF IRUPXOD SRZGHUV UHDG\ WR IHHG OLTXLGV DQG OLTXLG

FRQFHQWUDWHV

2 Analytical Technique

$Q\ DQDO\WLFDO WHFKQLTXH WKDW PHHWV WKH IROORZLQJ PHWKRG

SHUIRUPDQFH UHTXLUHPHQWV LV DFFHSWDEOH

3 Definitions

Accuracy (corresponds to the VIM definition for “trueness”)

²

7KH FORVHQHVV RI DJUHHPHQW EHWZHHQ WKH DYHUDJH RI DQ LQ¿QLWH

QXPEHU RI UHSOLFDWH PHDVXUHG TXDQWLW\ YDOXHV DQG D UHIHUHQFH

TXDQWLW\ YDOXH

Adult/pediatric formula.

²1XWULWLRQDOO\ FRPSOHWH VSHFLDOO\

IRUPXODWHG IRRG FRQVXPHG LQ OLTXLG IRUP ZKLFK PD\ FRQVWLWXWH

WKH VROH VRXUFH RI QRXULVKPHQW >$2$& 6WDNHKROGHU 3DQHO RQ ,QIDQW

)RUPXOD DQG $GXOW 1XWULWLRQDOV 63,)$1 @ PDGH IURP DQ\

FRPELQDWLRQ RI PLON VR\ ULFH ZKH\ K\GURO\]HG SURWHLQ VWDUFK

DQG DPLQR DFLGV ZLWK DQG ZLWKRXW LQWDFW SURWHLQ

Fluoride

²

7KH DQLRQ RU DQLRQLF VDOW FRPSRXQGV RI ÀXRULGH

) &$6 1R

Infant formula

²%UHDVW PLON VXEVWLWXWH VSHFLDOO\ PDQXIDFWXUHG

WR VDWLVI\ E\ LWVHOI WKH QXWULWLRQDO UHTXLUHPHQWV RI LQIDQWV GXULQJ

WKH ¿UVW PRQWKV RI OLIH XS WR WKH LQWURGXFWLRQ RI DSSURSULDWH

FRPSOHPHQWDU\ IHHGLQJ &RGH[ 6WDQGDUG ±

PDGH IURP

DQ\ FRPELQDWLRQ RI PLON VR\ ULFH ZKH\ K\GURO\]HG SURWHLQ

VWDUFK DQG DPLQR DFLGV ZLWK DQG ZLWKRXW LQWDFW SURWHLQ

Limit of quantitation (LOQ)

²7KH PLQLPXP FRQFHQWUDWLRQ

RU PDVV RI DQDO\WH LQ D JLYHQ PDWUL[ WKDW FDQ EH UHSRUWHG DV D

TXDQWLWDWLYH UHVXOW

Repeatability

²9DULDWLRQ DULVLQJ ZKHQ DOO HIIRUWV DUH PDGH

WR NHHS FRQGLWLRQV FRQVWDQW E\ XVLQJ WKH VDPH LQVWUXPHQW DQG

RSHUDWRU DQG UHSHDWLQJ GXULQJ D VKRUW WLPH SHULRG ([SUHVVHG DV WKH

UHSHDWDELOLW\ VWDQGDUG GHYLDWLRQ 6'

U

RU UHSHDWDELOLW\ UHODWLYH

VWDQGDUG GHYLDWLRQ 56'

U

Reproducibility

²7KH VWDQGDUG GHYLDWLRQ RU UHODWLYH VWDQGDUG

GHYLDWLRQ FDOFXODWHG IURP DPRQJ ODERUDWRU\ GDWD ([SUHVVHG DV

WKH UHSURGXFLELOLW\ VWDQGDUG GHYLDWLRQ 6'

5

RU UHSURGXFLELOLW\

UHODWLYH VWDQGDUG GHYLDWLRQ 56'

5

4 Method Performance Requirements

See

7DEOH

5 System Suitability Tests and/or Analytical Quality Control

6XLWDEOH PHWKRGV ZLOO LQFOXGH EODQN FKHFN VDPSOHV DQG FKHFN

VWDQGDUGV DW WKH ORZHVW SRLQW DQG PLGUDQJH SRLQW RI WKH DQDO\WLFDO

UDQJH

6 Reference Material(s)

1HLWKHU 1,67 QRU ,550 SURGXFH D FHUWL¿HG UHIHUHQFH PDWHULDO

IRU ÀXRULGH LQ LQIDQW IRUPXOD 7KH ÀXRULGH FRQWHQW RI 650 D

KDV QRW EHHQ GHWHUPLQHG DV RI 1RYHPEHU

7 Validation Guidance

5HFRPPHQGHG OHYHO RI YDOLGDWLRQ

Official Methods of

Analysis

60

8 Maximum Time-to-Result

1R PD[LPXP WLPH

Approved by Stakeholder Panel on Infant Formula and Adult

Nutritionals (SPIFAN). Final Version Date: September 6, 2014.

Effective Date: October 23, 2014.

7DEOH 0HWKRG SHUIRUPDQFH UHTXLUHPHQWV

a

3DUDPHWHU

0LQLPXP DFFHSWDEOH FULWHULD

$QDO\WLFDO UDQJH

±

b

/LPLW RI TXDQWLWDWLRQ /24

”

b

5HFRYHU\

±

±

±

±

5HSHDWDELOLW\ 56'

U

±

”

±

”

5HSURGXFLELOLW\ 56'

5

±

”

±

”

a

&RQFHQWUDWLRQV DSSO\ WR

a

µUHDG\ WR IHHG´ OLTXLGV ³DV LV´

b

UHFRQVWLWXWHG SRZGHUV J LQWR J GHLRQL]HG ZDWHU DQG

c

OLTXLG FRQFHQWUDWHV GLOXWHG E\ ZHLJKW ZLWK GHLRQL]HG ZDWHU

b

ȝJ J UHFRQVWLWXWHG ¿QDO SURGXFW